glp-1 receptor agonist weight loss plateau strategies Reduction with Agonists and Paths for Discontinuation While Maintaining Weight Maximizing Metabolic Synergy: A Review

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, according to a new study.

They now cost about Rs 1,0002,500 a month, and there's growing evidence pointing to benefits well beyond weight loss, including cardiovascular, metabolic, and liver health

This is where wellness starts to collide with pharma

Unlike GLP-1, GIP has little acute ...

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Learn key patient education tips for GLP-1 care management, the importance of multidisciplinary care teams and how remote care providers fit into the equation.